Peroxisome proliferator-activated receptor a (PPARa) is a ligand-dependent transcription factor which is activated by various endogenous as well as exogenous compounds. It is involved in the regulation of a variety of biological processes, such as nutrient metabolism, energy homoeostasis, immunological response and xenobiotic metabolism. Little is known about its expression during human prenatal development. We examined the spatio-temporal expression pattern of PPARa in human embryonic/foetal intestines, liver and kidney from the 5th to 20th week of prenatal life by indirect two-step immunohistochemistry. PPARa expression can already be detected in the early stages of prenatal development; as early as the 7th week of intrauterine development (IUD) in the intestines, 5th week of IUD in the liver and 6th week of IUD in the kidney. We found agedependent changes in the PPARa expression pattern in the intestines and kidney. These events occur approximately at the commencement of function of these organs. In the intestines, we detected an obvious change of the PPARa expression pattern along the crypt-villous axis in the 11th week of IUD. In the kidney, the most apparent change was increased expression of PPARa in glomeruli in the 12th week of IUD. Moreover, in the liver, we detected a strong positivity in part of the developing blood elements. Information about the spatio-temporal expression pattern of PPARa could be the first step in evaluating the potential harmful impact of a wide range of environmental or pharmaceutical compounds which serve as PPARa ligands on the developing human organism.Peroxisome proliferator-activated receptors (PPARs) are ligand-dependent transcription factors that belong to the nuclear receptor superfamily. PPARs consist of three members: peroxisome proliferator-activated receptor a (PPARa), PPARb/d and PPARc. The receptors are encoded by different genes and activated by different compounds. PPARa is well known as a regulator of nutrient metabolism and energy homoeostasis. Moreover, it is involved in the regulation of inflammation and immune response as well as xenobiotic metabolism [1]. After ligand binding, PPARs bind to the peroxisome proliferator response element in the promoter region of target genes as a heterodimer with retinoid X receptor (RXR). Beside ligands, the receptors interact with a huge number of co-activators and co-repressors. Furthermore, their transcriptional activity can also be modulated by cross-talk between phosphorylation and dephosporylation. The effect of these modifications depends on cellular context, receptor type and residue metabolized [2].PPARa is activated by a wide range of both endogenous and exogenous ligands, such as dietary fatty acids, eicosanoids, hypolipidaemic drugs, phthalates, pesticides, etc. The receptor is highly expressed in tissues with active fatty acid metabolism, such as the liver, heart muscle, intestine and kidney. Inappropriate activation of the receptor during prenatal development by xenobiotics can alter gene expression. ...